Related Experiment Videos
[Complement regulatory proteins CR 1, MCP, DAF, and MACIF levels in patients with Behçet's disease]
Insights
Patients with Behçet's disease exhibit reduced complement regulatory protein function before ocular attacks. This may be compensated by excessive complement production, impacting disease progression.
Area of Science:
- Immunology
- Rheumatology
Background:
- Serum complement levels are critically low in Behçet's disease patients preceding ocular attacks.
- Elevated anaphylatoxins (C3a, C5a) correlate negatively with complement component 50 (CH50) levels before ocular attacks.
Purpose of the Study:
- To investigate the role of complement regulatory proteins in Behçet's disease.
- To understand the interplay between complement activation and regulation in disease pathogenesis.
Main Methods:
- Evaluation of complement regulatory proteins, including C3b/C4b receptor (CR1), membrane cofactor protein (MCP), decay accelerating factor (DAF), and membrane attack complex inhibition factor (MACIF).
- Comparison of CH50 and alternative pathway CH50 (ACH50) levels between patients and controls.
Main Results:
- Reduced levels of CR1 and MCP, and a diminished tendency for DAF and MACIF function were observed.
- Despite regulatory protein deficiencies, mean CH50 and ACH50 levels were significantly higher in patients than controls.
Conclusions:
- The function of complement regulatory proteins appears globally decreased in Behçet's disease.
- Excessive complement production may be a compensatory mechanism for impaired regulation, potentially contributing to disease activity.
Abstract:
We previously reported that serum complements in patients with Behçet's disease were extremely low just before the ocular attack. On the other hand, C3a and C5a levels, which have anaphylactic activity and chemotactic activity for polymorphonuclear leucocytes, were higher just before the ocular attack than at the time of the ocular attack, and there was negative correlation between C3a/C5a and CH50. In this report, we evaluated complement regulatory proteins. The results of low levels of C3b/C4b receptor (CR1) and membrane cofactor protein (MCP), and low tendency of decay accelerating factor (DAF) and membrane attack complex inhibition factor (MACIF) suggested that the function of complement regulatory proteins in patients with Behçet's disease decreases as a whole. But mean levels of both CH50 and ACH50 were significantly higher than in the controls. Although it is unclear which is the cause and which is the result, we suppose the function of complement production works excessively and these phenomena are caused by making up for the lack of complement regulatory proteins.